Skip to main content

Relay Therapeutics, Inc.

RLAY
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001812364

In the last 90 days, Relay Therapeutics, Inc. insiders filed 0 open-market purchases and 14 sales; 259 institutions reported holding it in 13F filings for Q2 2026, worth $4.58B in total; Duquesne Family Office is the only superinvestor holding it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Relay Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
14 filings
5 insiders, $121.7M in total
Insiders trading
5
Net value
−$121.7M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Relay Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Relay Therapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Bergstrom Donald APresident, R&D399,130Sep 9, 20268
Catinazzo ThomasChief Financial Officer122,851Sep 9, 202612
Patel SanjivPresident and CEO519,500Sep 9, 20266
Rahmer PeterSee remarks223,657Aug 28, 20267
SB Investment Advisers (UK) Ltd10% Owner21,904,963IndirectAug 28, 20261
Softbank Vision Fund (Aiv M2) L.P.10% Owner21,904,963IndirectAug 28, 20261
SVF Pauling (Cayman) Ltd10% Owner21,904,963IndirectAug 28, 20261
Hill Linda ADirector–Jun 10, 20261
Ingram Douglas SDirector–Jun 10, 20261
Borisy AlexisDirector–Jun 10, 20261
Coats LonnelDirector–Jun 10, 20262
Dable Habib JDirector–Jun 10, 20262
Murcko MarkDirector996,952Jun 10, 20261
Mazumdar ClaireDirector–Jun 10, 20261
Adams BrianChief Legal Officer371,472Jul 30, 20250
Rubin JamiDirector67,242Jun 6, 20250
Kathiresan SekarDirector–Jun 6, 20250
Shawver LauraDirector40,000Jun 5, 20240
Porter AndyChief Administrative Officer45,164Nov 1, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jan 6, 2025 (view filing)Jan 2-64 daysRahmer PeterSee remarksSSale−80.9K$4.27−$345.6K−20.8%308.8K after3 lots10b5-1
Dec 31, 2024 (view filing)Dec 274 daysAdams BrianChief Legal OfficerSSale−299$4.38−$1.31K−0.1%321.6K after
Dec 31, 2024 (view filing)Dec 274 daysBergstrom Donald APresident, R&DSSale−657$4.38−$2.88K−0.1%520.1K after
Dec 31, 2024 (view filing)Dec 274 daysCatinazzo ThomasChief Financial OfficerSSale−4.87K$4.42−$21.5K−1.6%299.2K after2 lots10b5-1
Dec 31, 2024 (view filing)Dec 274 daysRahmer PeterSee remarksSSale−400$4.38−$1.75K−0.1%389.7K after
Dec 18, 2024 (view filing)Dec 162 daysPatel SanjivPresident and CEOSSale−100.0K$5.00−$500.0K−14.8%574.5K after10b5-1
Oct 30, 2024 (view filing)Oct 282 daysRahmer PeterSee remarksSSale−1.62K$6.06−$9.82K−0.4%390.1K after
Oct 30, 2024 (view filing)Oct 28-292 daysCatinazzo ThomasChief Financial OfficerSSale−9.10K$6.03−$54.9K−2.9%304.1K after3 lots10b5-1
Oct 30, 2024 (view filing)Oct 282 daysBergstrom Donald APresident, R&DSSale−2.69K$6.06−$16.3K−0.5%520.7K after
Oct 30, 2024 (view filing)Oct 282 daysAdams BrianChief Legal OfficerSSale−1.63K$6.06−$9.89K−0.5%321.9K after
Oct 1, 2024 (view filing)Sep 274 daysRahmer PeterSee remarksSSale−245$7.51−$1.84K−0.1%391.7K after
Oct 1, 2024 (view filing)Sep 274 daysCatinazzo ThomasChief Financial OfficerSSale−6.46K$7.46−$48.2K−2.0%313.2K after2 lots10b5-1
Oct 1, 2024 (view filing)Sep 274 daysBergstrom Donald APresident, R&DSSale−648$7.51−$4.87K−0.1%523.4K after
Oct 1, 2024 (view filing)Sep 274 daysAdams BrianChief Legal OfficerSSale−295$7.51−$2.22K−0.1%323.5K after
Jul 31, 2024 (view filing)Jul 292 daysCatinazzo ThomasChief Financial OfficerSSale−10.8K$8.56−$92.3K−3.3%319.6K after2 lots10b5-1
Jul 31, 2024 (view filing)Jul 29-312 daysRahmer PeterSee remarksSSale−42.4K$8.34−$353.1K−9.8%391.9K after4 lots10b5-1
Jul 31, 2024 (view filing)Jul 292 daysBergstrom Donald APresident, R&DSSale−2.70K$8.85−$23.9K−0.5%524.1K after
Jul 31, 2024 (view filing)Jul 292 daysAdams BrianChief Legal OfficerSSale−1.64K$8.85−$14.5K−0.5%323.8K after
Jul 29, 2024 (view filing)Jul 25-264 daysPatel SanjivPresident and CEOSSale−86.7K$9.12−$790.9K−10.2%766.1K after2 lots10b5-1
Jul 1, 2024 (view filing)Jun 274 daysBergstrom Donald APresident, R&DSSale−648$6.26−$4.06K−0.1%526.8K after
Jul 1, 2024 (view filing)Jun 274 daysRahmer PeterSee remarksSSale−245$6.26−$1.53K−0.1%432.2K after
Jul 1, 2024 (view filing)Jun 274 daysCatinazzo ThomasChief Financial OfficerSSale−9.37K$6.24−$58.5K−2.8%330.4K after2 lots10b5-1
Jul 1, 2024 (view filing)Jun 274 daysAdams BrianChief Legal OfficerSSale−295$6.26−$1.85K−0.1%325.5K after
Jun 5, 2024 (view filing)Jun 3-52 daysRahmer PeterSee remarksSSale−80.9K$6.70−$542.4K−15.8%432.4K after3 lots10b5-1
Apr 29, 2024 (view filing)Apr 29Same dayRahmer PeterSee remarksSSale−1.34K$6.38−$8.58K−0.3%513.3K after
Apr 29, 2024 (view filing)Apr 29Same dayAdams BrianChief Legal OfficerSSale−1.62K$6.38−$10.4K−0.5%325.8K after
Apr 29, 2024 (view filing)Apr 29Same dayCatinazzo ThomasChief Financial OfficerSSale−1.70K$6.38−$10.8K−0.5%339.8K after
Apr 29, 2024 (view filing)Apr 29Same dayBergstrom Donald APresident, R&DSSale−2.69K$6.38−$17.1K−0.5%527.4K after
Mar 29, 2024 (view filing)Mar 272 daysCatinazzo ThomasChief Financial OfficerSSale−348$7.70−$2.68K−0.1%341.5K after
Mar 29, 2024 (view filing)Mar 272 daysBergstrom Donald APresident, R&DSSale−765$7.70−$5.89K−0.1%530.1K after
Mar 29, 2024 (view filing)Mar 272 daysAdams BrianChief Legal OfficerSSale−348$7.70−$2.68K−0.1%327.4K after
Mar 29, 2024 (view filing)Mar 272 daysRahmer PeterSee remarksSSale−298$7.70−$2.29K−0.1%514.7K after
Jan 31, 2024 (view filing)Jan 292 daysRahmer PeterSee remarksSSale−1.65K$9.64−$15.9K−0.3%515.0K after
Jan 31, 2024 (view filing)Jan 292 daysCatinazzo ThomasChief Financial OfficerSSale−2.00K$9.64−$19.3K−0.6%341.8K after
Jan 31, 2024 (view filing)Jan 292 daysBergstrom Donald APresident, R&DSSale−3.18K$9.64−$30.6K−0.6%530.9K after
Jan 31, 2024 (view filing)Jan 292 daysAdams BrianChief Legal OfficerSSale−1.93K$9.64−$18.6K−0.6%327.7K after
Dec 29, 2023 (view filing)Dec 272 daysRahmer PeterSee remarksSSale−244$11.51−$2.81K−0.1%316.6K after
Dec 29, 2023 (view filing)Dec 272 daysCatinazzo ThomasChief Financial OfficerSSale−294$11.51−$3.38K−0.2%143.9K after
Dec 29, 2023 (view filing)Dec 272 daysBergstrom Donald APresident, R&DSSale−977$11.51−$11.2K−0.4%234.1K after
Dec 29, 2023 (view filing)Dec 272 daysAdams BrianChief Legal OfficerSSale−294$11.51−$3.38K−0.2%129.7K after
Nov 1, 2023 (view filing)Oct 302 daysRahmer PeterSee remarksSSale−1.35K$6.03−$8.16K−0.4%316.9K after
Nov 1, 2023 (view filing)Oct 302 daysCatinazzo ThomasChief Financial OfficerSSale−1.70K$6.03−$10.2K−1.2%144.1K after
Nov 1, 2023 (view filing)Oct 302 daysBergstrom Donald APresident, R&DSSale−3.45K$6.03−$20.8K−1.4%235.0K after
Nov 1, 2023 (view filing)Oct 302 daysAdams BrianChief Legal OfficerSSale−1.63K$6.03−$9.84K−1.2%130.0K after
Sep 29, 2023 (view filing)Sep 272 daysBergstrom Donald APresident, R&DSSale−648$8.38−$5.43K−0.3%238.5K after
Sep 29, 2023 (view filing)Sep 272 daysRahmer PeterSee remarksSSale−244$8.38−$2.04K−0.1%318.2K after
Sep 29, 2023 (view filing)Sep 272 daysCatinazzo ThomasChief Financial OfficerSSale−294$8.38−$2.46K−0.2%145.8K after
Sep 29, 2023 (view filing)Sep 272 daysAdams BrianChief Legal OfficerSSale−294$8.38−$2.46K−0.2%131.6K after
Jul 31, 2023 (view filing)Jul 283 daysRahmer PeterSee remarksSSale−1.35K$11.80−$16.0K−0.4%316.8K after
Jul 31, 2023 (view filing)Jul 283 daysCatinazzo ThomasChief Financial OfficerSSale−1.69K$11.80−$20.0K−1.1%146.1K after